Abstract

Aortic graft infection is a rare but threatening condition. Early recognition is important but might be challenging. A 25-year-old woman presented with Osler nodes, malaise, fever and multifocal osteomyelitis. Her medical history included a ganglioneuroma resection during her childhood, with aortic reconstruction. A positron emission tomography-computed tomography scan revealed an aortic graft infection. After 2 years of conservative treatment, the patient developed an aorto-enteric fistula, undergoing surgical intervention: graft removal and axillary-femoral bypass. At 20 months follow-up, she remains free of bacteremia. Therefore, graft infection should be considered even many years post aortic reconstruction. Individualized treatment can promote favourable outcomes.

Introduction

Aortic vascular grafts are increasingly used to treat life-threatening diseases, including advanced cancer [1]. However, graft-related complications, particularly infections, occur in up to 4% of cases, causing major morbidity and mortality [2–7].

Managing vascular graft infection is challenging. Antibiotics alone is frequently insufficient requiring graft removal, and revascularization [8]. While extra-anatomic bypasses were once the standard approach, in situ reconstruction has become favoured today [9]. Nonetheless, in contaminated fields, especially in the presence of secondary aortoenteric fistula, extra-anatomic bypass remains a viable option [10, 11]. Aortoenteric fistula mortality rates reach up to 57%.

This case highlights diagnostic challenges and management of a 27-year-old woman with aortoenteric erosion 19 years after aortic reconstruction.

Case report

A 25-year-old female presented to the outpatient clinic with recurrent, red, tender, and painful lesions on the plantar region of the right foot, which appeared every 15 days, accompanied by malaise and fever, occurring 1 month after initiation of methotrexate therapy. The plantar lesions were diagnosed by dermatologists as Osler nodes (Fig. 1). Consequently, methotrexate was discontinued, and investigations for potential septic embolization sources initiated.

Clinical and radiological findings at patient admission. Osler nodes (red, tender, painful lesions on the plantar region of the right foot); computed tomography scan shows perigraft fluid; positron emission tomography (PET) scan with 18F-fluorodeoxyglucose increased metabolic activity in the graft region in axial; and image of an enteroscopy showing the graft eroding the third portion of the duodenum.
Figure 1

Clinical and radiological findings at patient admission. Osler nodes (red, tender, painful lesions on the plantar region of the right foot); computed tomography scan shows perigraft fluid; positron emission tomography (PET) scan with 18F-fluorodeoxyglucose increased metabolic activity in the graft region in axial; and image of an enteroscopy showing the graft eroding the third portion of the duodenum.

The patient’s medical history included three abdominal surgeries: a major surgery to resect a ganglioneuroma affecting the abdominal aorta and the left kidney, where an aortic reconstruction with a Dacron graft (age 8), a cholecystectomy (age 21), and a laparotomy for acute abdominal obstructive syndrome, with segmental enterectomy and a sigmoid suture (age 23). At age 22 the patient developed a multifocal osteomyelitis involving the femur and tibia, with negative cultures. Nonspecific pulmonary imaging findings and a sputum rapid polymerase chain reaction (PCR) positive for traces of Mycobacterium tuberculosis led to the diagnosis of tuberculosis. She had rifampicin, isoniazid, pyrazinamide and ethambutol for one year, but persisted with clinical symptoms and elevated inflammatory markers. A hypothesis of chronic recurrent multifocal osteomyelitis was considered and methotrexate was started.

After echocardiogram resulted negative for endocarditis, computer tomography (CT) scan revealed a perigraft collection. A positron emission tomography-computed tomography (PET-CT) with 18F-Fluorodeoxyglucose scan revealed an infection at the site of the previous aortic reconstruction. Endoscopy was normal, and peripheral blood cultures were negative. Perigraft fluid culture (obtained under CT guidance) resulted negative. After multidisciplinary meeting it was decided for conservative treatment and the patient was discharged on sulfamethoxazole and trimethoprim.

After 6 months, the patient had an episode of bacteremia, receiving vancomycin and piperacillin-tazobactam for 2 weeks. She remained asymptomatic and was discharged with teicoplanin and ertapenem for 6 months. After that, the patient remained without antibiotic therapy.

After 2 years of conservative treatment, the patient had abdominal pain, fatigue, weight loss, intermittent fever, and an episode of moderate haematemesis. A CT scan revealed an aortoduodenal fistula, confirmed with an enteroscopy. In this context, a Klebsiella aerogenes susceptible only to carbapenems, polymyxins, and aminoglycosides was isolated in peripherical blood cultures.

Vancomycin and piperacillin–tazobactam were initiated, and the patient underwent a right axillary-to-femoral bypass using a 7-mm ring-reinforced expanded polytetrafluoroethylene graft. Immediately afterward, a median laparotomy was performed, the infected aortic graft was removed, and the infrarenal aorta was closed with Prolein 3–0 suture, preserving the integrity of the aortic bifurcation. A partial duodenectomy with duodenojejunal anastomosis was performed. At the end of surgery, distal pulses were palpable bilaterally, and limb perfusion was satisfactory.

The following day, the patient experienced haemodynamic deterioration, requiring epinephrine (0.3mcg/kg/h) and showing worsening perfusion of the left lower limb, despite the axillofemoral bypass remained patent. A femoral-femoral bypass was performed.

The patient remained in the ICU for 15 days and was discharged in good condition after 18 days of hospitalization. Culture of the explanted graft was positive for multidrug-sensitive Klebsiella pneumoniae, Escherichia coli (multisensitive), and Candida Albicans. The fungal pathogen was isolated after hospital discharge, and due to clinical stability, it was not treated. At discharge, she was prescribed ciprofloxacin and later it was exchanged to levofloxacin for the past year.

Eighteen months postoperatively, she underwent an aspiration thrombectomy due to acute graft thrombosis. At 24 months of follow-up, she remains free of bacteremia, with a patent bypass as shown in Fig. 2. A timeline in shown in Fig. 3.

Computed tomography angiography (CTA) showing the aorta and iliac arteries. (A) Pre-operative CTA shows the area of the previous aortic graft (*); (B) Post-operative CT scan shows the axillofemoral bypass (arrow) and the aortic ligation (*).
Figure 2

Computed tomography angiography (CTA) showing the aorta and iliac arteries. (A) Pre-operative CTA shows the area of the previous aortic graft (*); (B) Post-operative CT scan shows the axillofemoral bypass (arrow) and the aortic ligation (*).

Timeline of patient’s symptoms, signs, diagnosis and interventions. (A) Computed tomography (CT) scan highlighting the region of the aortic graft. (B) Bone scan revealing an osteogenic lesion in the left tibia; *RIPE: Rifampicin, isoniazid, pyrazinamide and ethambutol. (C) Positron emission tomography CT scan with 18F-fluorodeoxyglucose indicating infection of the aortic graft. (E) Enteroscopy showing erosion of the duodenal wall. (E) Osler nodes in the patient’s foot. (F) CT scan depicting the axillobifemoral bypass.
Figure 3

Timeline of patient’s symptoms, signs, diagnosis and interventions. (A) Computed tomography (CT) scan highlighting the region of the aortic graft. (B) Bone scan revealing an osteogenic lesion in the left tibia; *RIPE: Rifampicin, isoniazid, pyrazinamide and ethambutol. (C) Positron emission tomography CT scan with 18F-fluorodeoxyglucose indicating infection of the aortic graft. (E) Enteroscopy showing erosion of the duodenal wall. (E) Osler nodes in the patient’s foot. (F) CT scan depicting the axillobifemoral bypass.

Discussion

This report describes a 27-year-old patient who developed aortoduodenal erosion 19 years after an aortic reconstruction. Antibiotic therapy was effective for 2 years until the patient developed an aortoduodenal erosion, requiring graft removal, aortic ligation, and duodenectomy. Reconstruction was performed with an axillobifemoral bypass.

Conservative management of aortic graft infections is generally reserved for high-risk cases [10, 12, 13]. In this patient, surgical difficulties were anticipated due to three prior laparotomies, with limited information on initial tumour resection and aortic reconstruction. Although case series report a 30-day mortality of 100% with conservative therapy [10], our patient remained largely asymptomatic on antibiotics for 2 years. This is consistent with a retrospective study of 50 patients, which showed acceptable outcomes with microbiological-directed antibiotics and biofilm eradication [12].

In suitable surgical candidates, management typically involves the complete removal of the infected graft [10]. Historically, extra-anatomic reconstruction was preferred; however, it carries risks such as stump blowout and occlusion. Consequently, in situ reconstruction has become the preferred approach [10].

However, in this case, an axillofemoral bypass was selected due to a severely infected surgical site, with an aortoduodenal erosion and resistant bacteria identified. This choice is supported by data from a systematic review of 1467 patients showing lower mortality with this approach (31%) versus 47% for in situ reconstruction [11].

Nevertheless, there are concerns regarding the durability of this bypass in a young patient, prompting the consideration of elective in situ reconstruction if the bypass results in frequent reoperations. However, evidence suggests that femorofemoral bypass procedures are safe, with few reported infections [14–16], with a secondary patency rate of 99% over 4 years [16].

The description of this case is limited by fragmented follow-up data, limited details on initial procedure and delaying suspicion of graft infection.

Despite this, the case emphasizes the need for patient education, and vigilance in vascular graft management. Graft infection should be considered in the differential diagnosis, even years post-surgery. Individualized care and multidisciplinary management are vital for improved outcomes.

Conflict of interest statement

The authors have no disclosures.

Funding

No funding was provided.

References

1.

Kirchweger
 
P
,
Wundsam
 
HV
,
Fischer
 
I
, et al.  
Total resection of a giant retroperitoneal and mediastinal ganglioneuroma-case report and systematic review of the literature
.
World J Surg Oncol
 
2020
;
18
:
248
.

2.

Hobbs
 
SD
,
Kumar
 
S
,
Gilling-Smith
 
GL
.
Epidemiology and diagnosis of endograft infection
.
J Cardiovasc Surg (Torino)
 
2010
;
51
:
5
14
.

3.

Lyons
 
OT
,
Baguneid
 
M
,
Barwick
 
TD
, et al.  
Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC)
.
Eur J Vasc Endovasc Surg
 
2016
;
52
:
758
63
.

4.

Hobbs
 
SD
,
Kumar
 
S
,
Gilling-Smith
 
GL
.
Epidemiology and diag- nosis of endograft infection
.
J Cardiovasc Surg (Torino)
 
2010
;
51
:
5e14
.

5.

Numan
 
F
,
Gulsen
 
F
,
Solak
 
S
, et al.  
Management of endograft infections
.
J Cardiovasc Surg (Torino)
 
2011
;
52
:
205e 23
.

6.

Darouiche
 
RO
.
Treatment of infections associated with surgical implants
.
N Engl J Med
 
2004
;
350
:
1422
9
.

7.

Tatterton
 
MR
,
Homer-Vanniasinkam
 
S
.
Infections in vascular surgery
.
Injury
 
2011
;
42
:
S35
41
.

8.

Gharamti
 
A
,
Kanafani
 
ZA
.
Vascular graft infections: an update
.
Infect Dis Clin North Am
 
2018
;
32
:
789
809
.

9.

Hostalrich
 
A
,
Ozdemir
 
BA
,
Sfeir
 
J
, et al.  
Systematic review of native and graft-related aortic infection outcome managed with orthotopic xenopericardial grafts
.
J Vasc Surg
 
2019
;
69
:
614
8
.

10.

Chakfé
 
N
,
Diener
 
H
,
Lejay
 
A
, et al.  
Editor's choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections
.
Eur J Vasc Endovasc Surg
 
2020
;
59
:
339
84
.
Erratum in: Eur J Vasc Endovasc Surg 2020;60:958
.

11.

Bergqvist
 
D
,
Björck
 
M
.
Secondary Arterioenteric fistulation – a systematic literature analysis
.
Eur J Vasc Endovasc Surg
 
2009
;
37
:
31
42
.

12.

Kasa
 
K
,
Hirukawa
 
H
,
Fukuda
 
S
, et al.  
A case series of secondary aortoenteric fistula after open aortic aneurysm repair: timing and technique of surgery
.
Ann Vasc Dis
 
2022
;
15
:
324
8
.

13.

Lawrence
 
PF
.
Conservative treatment of aortic graft infection
.
Semin Vasc Surg
 
2011
;
24
:
199
204
.

14.

Galyfos
 
G
,
Charalampopoulos
 
G
,
Chamzin
 
A
, et al.  
Extra-anatomic bypass procedures for severe aortoiliac occlusive disease-a cohort study
.
Vascular
 
2025
;
33
:
87
95
.

15.

Ahmic
 
E
,
Swatek
 
P
,
Mykoliuk
 
I
, et al.  
Long-term outcomes of Femorofemoral crossover bypass versus endovascular revascularization in iliac artery occlusions: a retrospective study
.
J Clin Med
 
2025
;
14
:
2109
.

16.

Lipsitz
 
EC
,
Ohki
 
T
,
Veith
 
FJ
, et al.  
Patency rates of femorofemoral bypasses associated with endovascular aneurysm repair surpass those performed for occlusive disease
.
J Endovasc Ther
 
2003
;
10
:
1061
5
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.